{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-027246","form_type":"8-K","ticker":"COCP","cik":"0001412486","company_name":"Cocrystal Pharma, Inc.","filed_at":"2025-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.925034+00:00","generated_at":"2026-05-17T06:43:42.277228+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cocrystal Pharma announces up to $13M registered direct offering at $1.70/share","bullets":["$4.7M upfront from sale of 2,764,710 shares at $1.70; closing expected Sep 15, 2025.","Concurrent private placement of warrants to purchase up to 5,529,420 shares at $1.50, exercisable on issuance, 24-month term.","Potential additional gross proceeds of ~$8.3M if warrants fully exercised on cash basis.","H.C. Wainwright & Co. acting as exclusive placement agent.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-027246","json":"https://secwatch.observer/filing/0001641172-25-027246.json","markdown":"https://secwatch.observer/filing/0001641172-25-027246.md","text":"https://secwatch.observer/filing/0001641172-25-027246.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225027246/0001641172-25-027246-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412486/000164117225027246/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:43:42.277228+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}